Search - tctmd.com

Displaying 101 - 120 of 708

Sort: Relevancy | Date

Presentation TCT 2019

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Presenter: Peter Carson

September 28, 2019

Presentation TCT 2019

Transapical II: Tendyne — Device Description, Results, and Ongoing Studies

Presenter: Jason Rogers

September 28, 2019

Presentation TCT 2019

Transapical I: Intrepid — Device Description, Results, and Ongoing Studies

Presenter: Martin Leon

September 28, 2019

Presentation TCT 2019

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

Presenter: Nir Uriel

September 28, 2019

Presentation TCT 2019

Technical Hurdles in TMVR Development

Presenter: Juan Granada

September 28, 2019

Presentation TCT 2019

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

Presenter: Megha Reddy

September 28, 2019

Presentation TCT 2019

TMVR: Lessons From Surgery Not to Be Ignored

Presenter: Steven Bolling

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

Best Practices in Sterility Studies of Cardiovascular Devices: What Does the FDA Look For?

Presenter: Hiren Mistry

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Renal Failure

Presenter: Roland Schmieder

September 28, 2019

Presentation TCT 2019

Best Practices in Animal Studies of Cardiovascular Devices: What Does the FDA Look For?

Presenter: Natalie Miller

September 28, 2019

Presentation TCT 2019

Trial Design for Tricuspid Devices: Perspectives From the FDA

Presenter: Jaime Raben

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

Presenter: Christian Ukena

September 28, 2019

Presentation TCT 2019

Device-Based Autonomic Modulation in Heart Failure

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Best Practices in Biocompatibility Assessment of Cardiovascular Devices: What Does the FDA Look For?

Presenter: Claire Hambright

September 28, 2019

Presentation TCT 2019

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Presenter: Philipp Lurz

September 28, 2019

Presentation TCT 2019

Innovative Trial Designs in Device-Based Hypertension Treatment

Presenter: Konstantinos Tsioufis

September 28, 2019

Debate: Is a Clinical Outcomes Trial Mandatory Before Widespread Adoption of Device-Based Hypertension Therapies? - Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presentation TCT 2019

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Presenter: Bernard Gersh

September 28, 2019

Advertisement

State of the Art: Latest Insights into the Pathophysiology and Medical and Device-Based Therapies for HFpEF

Transapical II: Tendyne — Device Description, Results, and Ongoing Studies

Transapical I: Intrepid — Device Description, Results, and Ongoing Studies

State of the Art: Device-Based Therapies for Heart Failure and Reduced EF

Technical Hurdles in TMVR Development

After the Champagne for PMA Approval Come Your Obligations: Inspections, Postapproval Studies, Medical Device Reporting, and Recalls

TMVR: Lessons From Surgery Not to Be Ignored

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Best Practices in Sterility Studies of Cardiovascular Devices: What Does the FDA Look For?

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Device-Based Autonomic Modulation in Renal Failure

Best Practices in Animal Studies of Cardiovascular Devices: What Does the FDA Look For?

Trial Design for Tricuspid Devices: Perspectives From the FDA

Device-Based Autonomic Modulation in Supraventricular and Ventricular Arrhythmias

Device-Based Autonomic Modulation in Heart Failure

Best Practices in Biocompatibility Assessment of Cardiovascular Devices: What Does the FDA Look For?

What Are the Essential Differences Between Renal Denervation Devices and Procedures, and Do They Matter?

Innovative Trial Designs in Device-Based Hypertension Treatment

Yes, An Outcomes Study for Device-Based Hypertension Approaches Is Needed Before Widespread Use Can Be Recommended!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content